Diacomit (Stiripentol) Patent Expiration, LOE Window & CMS Spending

Diacomit (Stiripentol) by Biocodex Sa: FDA Orange Book LOE 2029-07-14, 0 AB generics, $21.4M 2024 CMS Part D & Medicaid spend, and 20 CA HCAI SB 17 wholesale price filings.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorBiocodex Sa
FDA Application & PathwayN206709 (NDA)
Exclusivity / Cliff HorizonNear-Term Cliff (2028-2030)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity Date2029-07-14
Orange Book Patents (*PED Extensions)0 patents (0 *PED)
Active AB-Rated Generic Competitors0
2024 CMS Total Public Spend$21.4M
2024 Medicare Part D Spend$1.7M
2024 Medicaid Spend$19.6M
Reported Wholesale Price Change (CA SB 17)20 WAC filings (max 40.5% 2-yr change)